XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.0.1
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Revenue:    
Total revenue $ 23,003 $ 22,297
Operating costs and expenses:    
Type of Cost, Good or Service [Extensible List] Product Sales [Member] Product Sales [Member]
Product costs $ 4,497 $ 3,743
Research and development 11,663 10,882
Selling, general and administrative 9,192 7,023
Acquired intangible asset amortization 1,089 556
Contingent consideration expense 3  
Total operating costs and expenses 26,444 22,204
Operating (loss) income (3,441) 93
Other expense:    
Investment income, net 26 41
Interest expense (136) (60)
Foreign exchange gain (loss) 33 (180)
Other expense (77) (199)
Loss before income taxes (3,518) (106)
Income tax benefit (provision) 706 (168)
Net loss $ (2,812) $ (274)
Basic net loss per share $ (0.20) $ (0.02)
Diluted net loss per share $ (0.20) $ (0.02)
Weighted average number of shares outstanding:    
Basic 13,878 13,668
Diluted 13,878 13,668
Product Sales [Member]    
Revenue:    
Total revenue $ 12,344 $ 10,102
Royalties and License Fees [Member]    
Revenue:    
Total revenue 8,099 9,334
Research, Development and Other [Member]    
Revenue:    
Total revenue $ 2,560 $ 2,861